Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Irinotecan Liposome; Drug: Oxaliplatin; Drug: 5-FU; Drug: LV; Drug: Bevacizumab; Drug: Cetuximab Sponsors: Shanghai Zhongshan Hospital; CSPC Ouyi Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | Eloxatin | Erbitux | Hospitals | Research